|
Volumn 6, Issue 3, 2009, Pages 159-
|
JUPITER strikes earth
|
Author keywords
[No Author keywords available]
|
Indexed keywords
C REACTIVE PROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PLACEBO;
ROSUVASTATIN;
TRIACYLGLYCEROL;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
DEATH;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
HEALTH CARE COST;
HEART INFARCTION;
HIGH RISK PATIENT;
HUMAN;
METABOLIC SYNDROME X;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
RISK REDUCTION;
STROKE;
TRIACYLGLYCEROL BLOOD LEVEL;
C-REACTIVE PROTEIN;
CARDIOVASCULAR DISEASES;
CHOLESTEROL, LDL;
CLINICAL TRIALS AS TOPIC;
FLUOROBENZENES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
PRIMARY PREVENTION;
PYRIMIDINES;
SULFONAMIDES;
TREATMENT OUTCOME;
|
EID: 61449128314
PISSN: 17434297
EISSN: 17434300
Source Type: Journal
DOI: 10.1038/ncpcardio1454 Document Type: Editorial |
Times cited : (4)
|
References (0)
|